François Le Loarer Selected Research

François Le Loarer Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 04/2012
20	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 11/2017
4	Tertiary Lymphoid Structures 01/2024 - 10/2022
3	Liposarcoma 10/2020 - 11/2017
3	Rhabdomyosarcoma 01/2020 - 01/2020
2	Fibrosarcoma 03/2023 - 06/2022
2	Giant Cell Tumors (Giant Cell Tumor) 01/2023 - 01/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2019 - 01/2019
2	Aggressive Fibromatosis (Desmoid) 01/2019 - 04/2012
2	Arthritis (Polyarthritis) 01/2015 - 12/2012
1	Disease Progression 11/2023
1	Melanoma (Melanoma, Malignant) 08/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Margins of Excision 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Mesenchymal Chondrosarcoma 10/2020
1	Myxoid Liposarcoma 06/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Giant Cell Tumor of Bone 01/2020
1	Neutropenia 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Dermatofibrosarcoma 11/2018
1	Necrosis 11/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2012
6	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2020
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
4	MyogeninIBA 12/2023 - 01/2019
3	Keratins (Keratin)IBA 11/2021 - 01/2020
3	AnthracyclinesIBA 01/2021 - 11/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2022
2	avelumabIBA 01/2024 - 01/2021
2	Trinitrotoluene (TNT)IBA 08/2023 - 04/2017
2	Phosphotransferases (Kinase)IBA 03/2023 - 06/2022
2	pembrolizumabIBA 10/2022 - 01/2020
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 06/2022 - 11/2018
2	DesminIBA 11/2021 - 01/2021
2	erdafitinibIBA 12/2020 - 10/2020
2	Aggrecans (Aggrecan)IBA 10/2020 - 10/2020
2	LigandsIBA 01/2020 - 12/2012
2	Imatinib Mesylate (Gleevec)FDA Link 08/2019 - 01/2019
2	palbociclibIBA 08/2019 - 01/2019
2	Sunitinib (Sutent)FDA Link 08/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2012
1	Inhibins (Inhibin)IBA 12/2023
1	Complementary DNA (cDNA)IBA 10/2023
1	Estrogens (Estrogen)FDA Link 10/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2023
1	CollagenIBA 10/2023
1	AntigensIBA 08/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Co-Repressor ProteinsIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Toll-Like Receptor 4IBA 10/2022
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	AntibodiesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	InterferonsIBA 01/2022
1	ParaffinIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	regorafenibIBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	monomethyl auristatin EIBA 03/2020
1	Immunoconjugates (Immunoconjugate)IBA 03/2020
1	atezolizumabIBA 01/2020
1	berzosertibIBA 01/2020
1	navoximodIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Denosumab FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	ChromatinIBA 01/2020
1	EnzymesIBA 01/2020
1	KynurenineIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	CytokinesIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2019
1	GadoliniumIBA 02/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	Vinyl Chloride (Chloroethylene)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	pazopanib FDA Link 01/2019
1	DioxinsIBA 01/2019
1	ChlorophenolsIBA 01/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2018
1	alpha 1 Chain Collagen Type IIBA 11/2018
1	TrabectedinIBA 11/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2017
1	rucaparibIBA 11/2017

Therapy/Procedure

6	Therapeutics 01/2024 - 04/2017
6	Drug Therapy (Chemotherapy) 11/2023 - 11/2017
6	Neoadjuvant Therapy 01/2022 - 12/2018
2	Aftercare (After-Treatment) 10/2022 - 01/2019
2	Immunotherapy 01/2022 - 01/2020
2	Radiotherapy 06/2020 - 01/2020
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 04/2017
1	Ligation 01/2022
1	Precision Medicine 03/2019